Wish I read today's presentation as makes it even better as relevant bit pasted from slide 14
----------------------------------------------------------------
Results show PromarkerD can predict:
Which patients with diabetes will progress to have a significant decline in kidney
function better than any other current known measure; and
Which people with ‘normal’ kidney function as measured by conventional tests are
at risk of kidney problems.
Specifically the clinical study found that 10% of patients had a significant & rapid
decline in kidney function over the 4 year study period and that PromarkerD correctly
predicted 67% of these individuals.
-----------------------------------------
so the 67% bit was just the prediction of which patients will have a 'significant" decline in kidney function as opposed to second bit also does which people are at risk of kidney problems.
Significantly also confirms again the 67% is better than any known current measure....
This seems to have been missed by the wider market but not our accumulator....
(20min delay)